_id
6911bd50ccc777a4e85d625e
Ticker
GLSI
Name
Greenwich Lifesciences Inc
Exchange
NASDAQ
Address
Building 14, Stafford, TX, United States, 77477
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://greenwichlifesciences.com
Description
Greenwich LifeSciences, Inc., a clinical-stage biopharmaceutical company, develops novel cancer immunotherapies for breast cancer and other HER2/neu-expressing cancers in the United States and Romania. Its lead product candidate is GP2, an immunotherapy, which is in Phase III clinical trial to prevent breast cancer recurrences in patients who have previously undergone surgery. The company also develops FLAMINGO-01, which is in Phase III clinical trial designed to evaluate the safety and efficacy of GLSI-100 (GP2 + GM-CSF) in HER2 positive breast cancer patients. Greenwich LifeSciences, Inc. was formerly known as Norwell, Inc. and changed its name to Greenwich LifeSciences, Inc. in March 2018. The company was incorporated in 2006 and is headquartered in Stafford, Texas.
Last Close
11.27
Volume
35675
Current Price
10.73
Change
-4.791481810115343
Last Updated
2025-11-30T19:25:42.612Z
Image
data:image/webp;base64,UklGRrAHAABXRUJQVlA4WAoAAAAQAAAAPwAAPwAAQUxQSGwDAAABGTVtG7A4HWci+h++Smht215IttIam41l85DbxtG69qH9Z2zbtm3be+xp26xhK/kDb3dmJjXTVd0REzABJAqtY2Rh1q1dmwZakoSIIC+bGVYJBOVt5giJEAKNDIiMlLhKQNg6RTqbbGXRTyehHBLDedoJRx1xzCnOdJ6TLnWNK5xvjyZ0lHqtmfTpgKzHHVM51VkudNLlrneDS5xg0aAOBVvtZ9HMx8qJKKCBXpvtahc71z5qcXS6bSO6qCh0h4MuVD2ulqQWYcPosF1KE+KIYkq0Wux11DaNAGgUxMRolz5Esdc2O8VuLTRiAMzJT95lq3YTQGNQHSOTXgSgkZe8RTdQamSyRrgAmJNbi1361fOjBQqSNHohX3kLAYqrvAFcctMx2armB2COBiWIg5tDs5yMUCaWclDbQHVBRA5ah8kTAMzhoNgpLWRcDl3kdQDgoLrNsJ+pWbbYzg8symP0Epbbb6saE07c4R/LNLHoFscEMr72mSVaPVoZEIx+TE0BsNHLB6x+5XchXoAwsmJG5vKfALM+bszUYr70FsCog4QZ8Jc8AW0MdAiGH/GsHkgDy097m9mcCKbe9CkLSRBT6z/oJaKY+tE/2okEpv4yrN6cDKb+U9WCYGrAEA3OmeJcCMGUEBLOFs9ISAJTKWlBIZwpXnPzUJiSZRu7VaZWw6w2qkxVqk7wU1gK8JGseGwwpFaiAIchLsxkWNXTI8D/MIsZB68OACb9ZAYztbU+APjvyhJWJqwYEUCSzahhSWyUShE6ABAy7GdTmAhxyiCW/88HBjAxaMQWWcZ87i9+DKT9Q2mTBU4/W1+lbkXodUD2tD+87nfU/W9aLyLXWfLXfhRGFZ9iE9Ihp5Rx3/nQv6ia5hCnhTwHfED5SZmatCljPDYDoDEnF5/vKR/5DzWrdi4ZBACB7BzA/973qndZURHwL7sECwAaAjkKAKXvvOElPwqjIO1/M8rE0jnInQOYUnneAz6hSIpTGvIvg37tlslXAIgb9pZ7vew3SlHcXEZYdUAxE6Z95WkPeMxnKmEFSXFSxskaW7QgAPA5hULGgFc85H4v+041SJLXnBgnHyskEMsLFNNj0FfUe93odo9R3/eln/xlgJYkKa6mRJT9lAad+qkaWYoc8p/3POomd3jUS96TQ1REWJBCFBhWUDggHgQAANATAJ0BKkAAQAA+tUqbSickIiGuG2xw4BaJbACuT5dQjyN9B9s2/L543TVd5gn33NrAQxlzwowOyiMyV1d+uoT+rG+AfsA17FDLhar4o1ISvfwZvUjza7FPuoDH7SMyC+fTm/8wvvE8uBybHhDZHgdueDh/vf3RJTillv5dzy12oPNu38KZvPuXPGBU7/NJmTBrrkdk4xkDow5slFpiEkthj7WezvEAAP7/GtqxWK+VPJfL9sH/587e9p2oNNKoU9gvzFP1dPhXGQGSEwCTfbas11/9vW3Q5SjWl0hmItgnFodwhoGq43IjCJ/Pu5wUCfEflvVGtqWoEz/kcLhkUDqSWVMBOtzooo1GBKLaiX1rXxHRDXoB1hVUkBapFSsjM9M8KZRadvQAAoIvG/jn80ZyD7tLmAk1hnoeck+J/MWoc5iydr9KwMk65p4iJOiGPKQcuAelfSoLWWFt/82DqyYK/6wNK9DY+LdN7yiOYzzVpohe4uzthzBAPjP0e3lsaN3QnB8ApkUaDn/5MW8ldj5FR0xD8mG7jf6TkalgnM7uowCTidrDl3+axNOIQSkHBhZjlcuqAC+bmKAUVREBfuHFVRd3/CNMiZDr5riSl0c2Au0z0lksxHSuRMd+MNq/miSSUlMsov+z/wJ06ikENp544bRHEHOyrMJdgzxuqZLoJ1vRjtWFjYhhyh9eu5uRpho5kDZGl8ifS5oD6dGvfTt22fMrm5eL6LyxziQHBB1p/9+6ymqgRjA/td2ADXtmDlptaw+xUujf248DZQi8S6rwHjJh4w4kRO+E9/PqmvJIE6PSeP6uLP2+7X5UtMKKuohbknbuybRQmN5u4Jpx1/I1hRfdfNOqwgGi3HqjnIKHj2JO8adpLUkBz6NFWHWrmurtRxdLfKBJwTvC8ePunYzSbFdzqCTXT42mxQ+p0nOR61l6yNVY1Nntb9ek1gKnk/8AJyoY6P6ThALKQfZR+hh5beBzObskqcaH/lvZ/Hkw51mwePppN+PzAz42GxQd7tSLqxhcDElYLWXRT8+XCliIVp1bDePgGVnESaKBuyi38ALKY7+uCpngl4754IewF/R6e4MNaFxayTHMA3eyrz+tOlRfzsw2bFnrulA8oGO2GXm3BPtpULXIdssDAM/9k/lq33kI8RfjD32khJxfCaGSqv8fK4aCh4aEftz2Ly17u7gJgrUfUQyBMdaqv7NsPGY5u0YsK0Fe+AX0GsR8wEIGiDLdbepuVkCO1xgwtokZIWHCVrhco6ugcaDgTtxyZxDVisdqdzdS4+jo630BXUEXpWc3Z45xkJCMjDcf7EDDg3Jx9zFW/qzzgph6z6Ag14evdfaRDunCgEZ/pLxEh63WMM/mcMpvMwGpqttIOP4IFZIm9AIRYU+f1AFOgAA=
Ipo Date
2020-09-25T00:00:00.000Z
Market Cap
120950120
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Rating
4
Target Price
45
Strong Buy
0
Buy
1
Hold
0
Sell
0
Strong Sell
0
Current Quarter
2025-09-30
Revenue
0
Cost Of Revenue
-
Gross Profit
-
Operating Expenses
4174642
Operating Income
-4174642
Interest Expense
-
Pretax Income
-4151845
Net Income
-4151845
Eps
-0.3043565814143198
Dividends Per Share
-
Shares Outstanding
13854539
Income Tax Expense
-
EBITDA
-4151845
Operating Margin
-
Total Other Income Expense Net
22797
Cash
3806978
Short Term Investments
-
Receivables
-
Inventories
-
Total Current Assets
3806978
Property Plant Equipment
-
Total Assets
3806978
Payables
1108886
Short Term Debt
-
Long Term Debt
-
Total Liabilities
1622000
Equity
2184977
Depreciation
0
Change In Working Capital
-63608
Cash From Operations
-2671239
Capital Expenditures
7
Cash From Investing
-
Cash From Financing
3353116
Net Change In Cash
681877
PE
-
PB
66.99020187397853
ROE
-190.0177896609438
ROA
-109.05881252794212
FCF
-2671246
Fcf Percent
-
Piotroski FScore
1
Health Score
31
Deep Value Investing Score
2
Defensive Investing Score
6.5
Dividend Investing Score
1.5
Economic Moat Investing Score
3.3
Garp Investing Score
1.5
Growth Investing Score
0.5
Momentum Investing Score
2.5
Net Net Investing Score
2.5
Quality Investing Score
2
Value Investing Score
4
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
0
Quarters > 0 > income Statement > cost Of Revenue
-
Quarters > 0 > income Statement > gross Profit
-
Quarters > 0 > income Statement > operating Expenses
4174642
Quarters > 0 > income Statement > operating Income
-4174642
Quarters > 0 > income Statement > interest Expense
-
Quarters > 0 > income Statement > pretax Income
-4151845
Quarters > 0 > income Statement > net Income
-4151845
Quarters > 0 > income Statement > eps
-0.3043565814143198
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
13641384
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-4151845
Quarters > 0 > income Statement > operating Margin
-
Quarters > 0 > income Statement > total Other Income Expense Net
22797
Quarters > 0 > balance Sheet > cash
3806978
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
-
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
3806978
Quarters > 0 > balance Sheet > property Plant Equipment
-
Quarters > 0 > balance Sheet > total Assets
3806978
Quarters > 0 > balance Sheet > payables
1108886
Quarters > 0 > balance Sheet > short Term Debt
-
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
1622000
Quarters > 0 > balance Sheet > equity
2184977
Quarters > 0 > cash Flow > net Income
-4151845
Quarters > 0 > cash Flow > depreciation
0
Quarters > 0 > cash Flow > change In Working Capital
-63608
Quarters > 0 > cash Flow > cash From Operations
-2671239
Quarters > 0 > cash Flow > capital Expenditures
7
Quarters > 0 > cash Flow > cash From Investing
-
Quarters > 0 > cash Flow > cash From Financing
3353116
Quarters > 0 > cash Flow > net Change In Cash
681877
Quarters > 0 > ratios > PE
-0.3043565814143198
Quarters > 0 > ratios > PB
66.99020187397853
Quarters > 0 > ratios > ROE
-190.0177896609438
Quarters > 0 > ratios > ROA
-109.05881252794212
Quarters > 0 > ratios > FCF
-2671246
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
31
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
0
Quarters > 1 > income Statement > cost Of Revenue
876
Quarters > 1 > income Statement > gross Profit
-876
Quarters > 1 > income Statement > operating Expenses
4045953
Quarters > 1 > income Statement > operating Income
-4045953
Quarters > 1 > income Statement > interest Expense
-
Quarters > 1 > income Statement > pretax Income
-4025278
Quarters > 1 > income Statement > net Income
-4025278
Quarters > 1 > income Statement > eps
-0.30104577950626366
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
13370983
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-4045077
Quarters > 1 > income Statement > operating Margin
-
Quarters > 1 > income Statement > total Other Income Expense Net
20675
Quarters > 1 > balance Sheet > cash
3125101
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
-
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
3125101
Quarters > 1 > balance Sheet > property Plant Equipment
-
Quarters > 1 > balance Sheet > total Assets
3125101
Quarters > 1 > balance Sheet > payables
1075631
Quarters > 1 > balance Sheet > short Term Debt
-
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
1685609
Quarters > 1 > balance Sheet > equity
1439492
Quarters > 1 > cash Flow > net Income
-4025278
Quarters > 1 > cash Flow > depreciation
876
Quarters > 1 > cash Flow > change In Working Capital
247085
Quarters > 1 > cash Flow > cash From Operations
-2233103
Quarters > 1 > cash Flow > capital Expenditures
3
Quarters > 1 > cash Flow > cash From Investing
-
Quarters > 1 > cash Flow > cash From Financing
2608245
Quarters > 1 > cash Flow > net Change In Cash
375142
Quarters > 1 > ratios > PE
-0.30104577950626366
Quarters > 1 > ratios > PB
99.66755465817108
Quarters > 1 > ratios > ROE
-279.6318423443826
Quarters > 1 > ratios > ROA
-128.80473303102843
Quarters > 1 > ratios > FCF
-2233106
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
25
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
3612
Quarters > 2 > income Statement > cost Of Revenue
903
Quarters > 2 > income Statement > gross Profit
-903
Quarters > 2 > income Statement > operating Expenses
3282332
Quarters > 2 > income Statement > operating Income
-3282332
Quarters > 2 > income Statement > interest Expense
223008
Quarters > 2 > income Statement > pretax Income
-3258362
Quarters > 2 > income Statement > net Income
-3258362
Quarters > 2 > income Statement > eps
-0.24737868839328386
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
13171555
Quarters > 2 > income Statement > income Tax Expense
2538104
Quarters > 2 > income Statement > EBITDA
-3281429
Quarters > 2 > income Statement > operating Margin
-90872.97895902547
Quarters > 2 > income Statement > total Other Income Expense Net
23970
Quarters > 2 > balance Sheet > cash
2749959
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
-
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
2749959
Quarters > 2 > balance Sheet > property Plant Equipment
-
Quarters > 2 > balance Sheet > total Assets
2750835
Quarters > 2 > balance Sheet > payables
827036
Quarters > 2 > balance Sheet > short Term Debt
-
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
1438524
Quarters > 2 > balance Sheet > equity
1312311
Quarters > 2 > cash Flow > net Income
-3258362
Quarters > 2 > cash Flow > depreciation
903
Quarters > 2 > cash Flow > change In Working Capital
-121209
Quarters > 2 > cash Flow > cash From Operations
-1834454
Quarters > 2 > cash Flow > capital Expenditures
4
Quarters > 2 > cash Flow > cash From Investing
-
Quarters > 2 > cash Flow > cash From Financing
492423
Quarters > 2 > cash Flow > net Change In Cash
-1342031
Quarters > 2 > ratios > PE
-0.24737868839328386
Quarters > 2 > ratios > PB
107.69610644885245
Quarters > 2 > ratios > ROE
-248.29190641547623
Quarters > 2 > ratios > ROA
-118.44992520452881
Quarters > 2 > ratios > FCF
-1834458
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-507.87873754152827
Quarters > 2 > health Score
17
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
0
Quarters > 3 > income Statement > cost Of Revenue
-
Quarters > 3 > income Statement > gross Profit
-
Quarters > 3 > income Statement > operating Expenses
8084161
Quarters > 3 > income Statement > operating Income
-8084161
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
-8040219
Quarters > 3 > income Statement > net Income
-8040219
Quarters > 3 > income Statement > eps
-0.6112966366143483
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
13152729
Quarters > 3 > income Statement > income Tax Expense
-
Quarters > 3 > income Statement > EBITDA
-
Quarters > 3 > income Statement > operating Margin
-
Quarters > 3 > income Statement > total Other Income Expense Net
-
Quarters > 3 > balance Sheet > cash
4091990
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
-
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
4091990
Quarters > 3 > balance Sheet > property Plant Equipment
-
Quarters > 3 > balance Sheet > total Assets
4093769
Quarters > 3 > balance Sheet > payables
1177536
Quarters > 3 > balance Sheet > short Term Debt
-
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
1559733
Quarters > 3 > balance Sheet > equity
2534036
Quarters > 3 > cash Flow > net Income
-8040220
Quarters > 3 > cash Flow > depreciation
903
Quarters > 3 > cash Flow > change In Working Capital
717349
Quarters > 3 > cash Flow > cash From Operations
-1852206
Quarters > 3 > cash Flow > capital Expenditures
0
Quarters > 3 > cash Flow > cash From Investing
-
Quarters > 3 > cash Flow > cash From Financing
121829
Quarters > 3 > cash Flow > net Change In Cash
-1730377
Quarters > 3 > ratios > PE
-0.6112966366143483
Quarters > 3 > ratios > PB
55.69328224618751
Quarters > 3 > ratios > ROE
-317.28905982393303
Quarters > 3 > ratios > ROA
-196.40138464090182
Quarters > 3 > ratios > FCF
-1852206
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-
Quarters > 3 > health Score
31
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
0
Annuals > 0 > income Statement > cost Of Revenue
3612
Annuals > 0 > income Statement > gross Profit
-3612
Annuals > 0 > income Statement > operating Expenses
16011817
Annuals > 0 > income Statement > operating Income
-16011817
Annuals > 0 > income Statement > interest Expense
-
Annuals > 0 > income Statement > pretax Income
-15788809
Annuals > 0 > income Statement > net Income
-15788809
Annuals > 0 > income Statement > eps
-1.2131626940082991
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
13014585
Annuals > 0 > income Statement > income Tax Expense
-
Annuals > 0 > income Statement > EBITDA
-15785197
Annuals > 0 > income Statement > operating Margin
-
Annuals > 0 > income Statement > total Other Income Expense Net
223008
Annuals > 0 > balance Sheet > cash
4091990
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
-
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
4091990
Annuals > 0 > balance Sheet > property Plant Equipment
-
Annuals > 0 > balance Sheet > total Assets
4093769
Annuals > 0 > balance Sheet > payables
1177536
Annuals > 0 > balance Sheet > short Term Debt
-
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
1559733
Annuals > 0 > balance Sheet > equity
2534036
Annuals > 0 > cash Flow > net Income
-15788809
Annuals > 0 > cash Flow > depreciation
3612
Annuals > 0 > cash Flow > change In Working Capital
1265327
Annuals > 0 > cash Flow > cash From Operations
-7266543
Annuals > 0 > cash Flow > capital Expenditures
3
Annuals > 0 > cash Flow > cash From Investing
-
Annuals > 0 > cash Flow > cash From Financing
4369109
Annuals > 0 > cash Flow > net Change In Cash
-2897434
Annuals > 0 > ratios > PE
-1.2131626940082991
Annuals > 0 > ratios > PB
44.836508656546314
Annuals > 0 > ratios > ROE
-623.0696406838736
Annuals > 0 > ratios > ROA
-385.6790405125448
Annuals > 0 > ratios > FCF
-7266546
Annuals > 0 > ratios > Piotroski FScore
1
Annuals > 0 > ratios > fcf Percent
-
Annuals > 0 > health Score
23
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
0
Annuals > 1 > income Statement > cost Of Revenue
3612
Annuals > 1 > income Statement > gross Profit
-3612
Annuals > 1 > income Statement > operating Expenses
9327866
Annuals > 1 > income Statement > operating Income
-9327866
Annuals > 1 > income Statement > interest Expense
-
Annuals > 1 > income Statement > pretax Income
-8891803
Annuals > 1 > income Statement > net Income
-8891803
Annuals > 1 > income Statement > eps
-0.692067933436409
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
12848165
Annuals > 1 > income Statement > income Tax Expense
-2
Annuals > 1 > income Statement > EBITDA
-9324254
Annuals > 1 > income Statement > operating Margin
-
Annuals > 1 > income Statement > total Other Income Expense Net
436063
Annuals > 1 > balance Sheet > cash
6989424
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
-
Annuals > 1 > balance Sheet > inventories
-
Annuals > 1 > balance Sheet > total Current Assets
6989424
Annuals > 1 > balance Sheet > property Plant Equipment
-
Annuals > 1 > balance Sheet > total Assets
6994815
Annuals > 1 > balance Sheet > payables
35472
Annuals > 1 > balance Sheet > short Term Debt
-
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
294406
Annuals > 1 > balance Sheet > equity
6700409
Annuals > 1 > cash Flow > net Income
-8891803
Annuals > 1 > cash Flow > depreciation
3612
Annuals > 1 > cash Flow > change In Working Capital
31501
Annuals > 1 > cash Flow > cash From Operations
-6478602
Annuals > 1 > cash Flow > capital Expenditures
0
Annuals > 1 > cash Flow > cash From Investing
-
Annuals > 1 > cash Flow > cash From Financing
0
Annuals > 1 > cash Flow > net Change In Cash
-6478602
Annuals > 1 > ratios > PE
-0.692067933436409
Annuals > 1 > ratios > PB
16.73994534512744
Annuals > 1 > ratios > ROE
-132.70537664193336
Annuals > 1 > ratios > ROA
-127.11991668114166
Annuals > 1 > ratios > FCF
-6478602
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-
Annuals > 1 > health Score
26
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
0
Annuals > 2 > income Statement > cost Of Revenue
3612
Annuals > 2 > income Statement > gross Profit
-3612
Annuals > 2 > income Statement > operating Expenses
8040254
Annuals > 2 > income Statement > operating Income
-8040254
Annuals > 2 > income Statement > interest Expense
215017
Annuals > 2 > income Statement > pretax Income
-7825237
Annuals > 2 > income Statement > net Income
-7825237
Annuals > 2 > income Statement > eps
-0.6059570315524854
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
12913848
Annuals > 2 > income Statement > income Tax Expense
-215017
Annuals > 2 > income Statement > EBITDA
-8036642
Annuals > 2 > income Statement > operating Margin
-
Annuals > 2 > income Statement > total Other Income Expense Net
215017
Annuals > 2 > balance Sheet > cash
13468026
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
-
Annuals > 2 > balance Sheet > inventories
-
Annuals > 2 > balance Sheet > total Current Assets
13468026
Annuals > 2 > balance Sheet > property Plant Equipment
-
Annuals > 2 > balance Sheet > total Assets
13477029
Annuals > 2 > balance Sheet > payables
220845
Annuals > 2 > balance Sheet > short Term Debt
-
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
262905
Annuals > 2 > balance Sheet > equity
13214124
Annuals > 2 > cash Flow > net Income
-7825237
Annuals > 2 > cash Flow > depreciation
3612
Annuals > 2 > cash Flow > change In Working Capital
-122267
Annuals > 2 > cash Flow > cash From Operations
-6200027
Annuals > 2 > cash Flow > capital Expenditures
3
Annuals > 2 > cash Flow > cash From Investing
-
Annuals > 2 > cash Flow > cash From Financing
-7536216
Annuals > 2 > cash Flow > net Change In Cash
-13736243
Annuals > 2 > ratios > PE
-0.6059570315524854
Annuals > 2 > ratios > PB
8.531620638643924
Annuals > 2 > ratios > ROE
-59.21873443899875
Annuals > 2 > ratios > ROA
-58.06351681813551
Annuals > 2 > ratios > FCF
-6200030
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-
Annuals > 2 > health Score
26
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
0
Annuals > 3 > income Statement > cost Of Revenue
3612
Annuals > 3 > income Statement > gross Profit
-3612
Annuals > 3 > income Statement > operating Expenses
4597943
Annuals > 3 > income Statement > operating Income
-4597943
Annuals > 3 > income Statement > interest Expense
27367
Annuals > 3 > income Statement > pretax Income
-4570576
Annuals > 3 > income Statement > net Income
-4570576
Annuals > 3 > income Statement > eps
-0.35310017649693676
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
12944134
Annuals > 3 > income Statement > income Tax Expense
-27367
Annuals > 3 > income Statement > EBITDA
-4594331
Annuals > 3 > income Statement > operating Margin
-
Annuals > 3 > income Statement > total Other Income Expense Net
27367
Annuals > 3 > balance Sheet > cash
27204269
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
-
Annuals > 3 > balance Sheet > inventories
-
Annuals > 3 > balance Sheet > total Current Assets
27204269
Annuals > 3 > balance Sheet > property Plant Equipment
-
Annuals > 3 > balance Sheet > total Assets
27216884
Annuals > 3 > balance Sheet > payables
220845
Annuals > 3 > balance Sheet > short Term Debt
-
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
385172
Annuals > 3 > balance Sheet > equity
26831712
Annuals > 3 > cash Flow > net Income
-4570576
Annuals > 3 > cash Flow > depreciation
3612
Annuals > 3 > cash Flow > change In Working Capital
-385166
Annuals > 3 > cash Flow > cash From Operations
-4291548
Annuals > 3 > cash Flow > capital Expenditures
0
Annuals > 3 > cash Flow > cash From Investing
-
Annuals > 3 > cash Flow > cash From Financing
2835442
Annuals > 3 > cash Flow > net Change In Cash
-1456106
Annuals > 3 > ratios > PE
-0.35310017649693676
Annuals > 3 > ratios > PB
4.211519929104785
Annuals > 3 > ratios > ROE
-17.034231732958375
Annuals > 3 > ratios > ROA
-16.793164125621434
Annuals > 3 > ratios > FCF
-4291548
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-
Annuals > 3 > health Score
29
Valuation > metrics > PE
-0.3043565814143198
Valuation > metrics > PB
66.99020187397853
Valuation > final Score
20
Valuation > verdict
2133.0% Overvalued
Profitability > metrics > ROE
-190.0177896609438
Profitability > metrics > ROA
-109.05881252794212
Profitability > final Score
15
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.7423419102352107
Risk > final Score
68
Risk > verdict
High
Liquidity > metrics > Current Ratio
3.433155437078293
Liquidity > metrics > Quick Ratio
3.433155437078293
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
20
Prev Valuations > 1
20
Prev Valuations > 2
20
Prev Profitabilities > 0
15
Prev Profitabilities > 1
0
Prev Profitabilities > 2
15
Prev Risks > 0
-787
Prev Risks > 1
-29
Prev Risks > 2
68
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2025-12-14T00:33:23.199Z
Earnings History > 0 > period
2025-09-30
Earnings History > 0 > report Date
2025-11-10
Earnings History > 0 > date
2025-09-30
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-0.3
Earnings History > 0 > eps Estimate
-0.23
Earnings History > 0 > eps Difference
-0.07
Earnings History > 0 > surprise Percent
-30.4348
Earnings History > 1 > period
2025-06-30
Earnings History > 1 > report Date
2025-08-11
Earnings History > 1 > date
2025-06-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-0.3
Earnings History > 1 > eps Estimate
-0.24
Earnings History > 1 > eps Difference
-0.06
Earnings History > 1 > surprise Percent
-25
Earnings History > 2 > period
2025-03-31
Earnings History > 2 > report Date
2025-05-19
Earnings History > 2 > date
2025-03-31
Earnings History > 2 > before After Market
AfterMarket
Earnings History > 2 > currency
USD
Earnings History > 2 > eps Actual
-0.25
Earnings History > 2 > eps Estimate
-0.24
Earnings History > 2 > eps Difference
-0.01
Earnings History > 2 > surprise Percent
-4.1667
Earnings History > 3 > period
2024-12-31
Earnings History > 3 > report Date
2025-02-26
Earnings History > 3 > date
2024-12-31
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
-
Earnings History > 3 > eps Actual
-0.61
Earnings History > 3 > eps Estimate
-0.21
Earnings History > 3 > eps Difference
-0.4
Earnings History > 3 > surprise Percent
-190.4762
Earnings History > 4 > period
2024-09-30
Earnings History > 4 > report Date
2024-11-08
Earnings History > 4 > date
2024-09-30
Earnings History > 4 > before After Market
AfterMarket
Earnings History > 4 > currency
USD
Earnings History > 4 > eps Actual
-0.2
Earnings History > 4 > eps Estimate
-0.21
Earnings History > 4 > eps Difference
0.01
Earnings History > 4 > surprise Percent
4.7619
Earnings History > 5 > period
2024-06-30
Earnings History > 5 > report Date
2024-08-21
Earnings History > 5 > date
2024-06-30
Earnings History > 5 > before After Market
AfterMarket
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
-0.2
Earnings History > 5 > eps Estimate
-0.2
Earnings History > 5 > eps Difference
0
Earnings History > 5 > surprise Percent
0
Earnings History > 6 > period
2024-03-31
Earnings History > 6 > report Date
2024-05-20
Earnings History > 6 > date
2024-03-31
Earnings History > 6 > before After Market
AfterMarket
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
-0.19
Earnings History > 6 > eps Estimate
-0.2
Earnings History > 6 > eps Difference
0.01
Earnings History > 6 > surprise Percent
5
Earnings History > 7 > period
2023-12-31
Earnings History > 7 > report Date
2024-03-31
Earnings History > 7 > date
2023-12-31
Earnings History > 7 > before After Market
AfterMarket
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
-0.2138
Earnings History > 7 > eps Estimate
-0.22
Earnings History > 7 > eps Difference
0.0062
Earnings History > 7 > surprise Percent
2.8182
Earnings History > 8 > period
2023-09-30
Earnings History > 8 > report Date
2023-10-19
Earnings History > 8 > date
2023-09-30
Earnings History > 8 > before After Market
AfterMarket
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
-0.1862
Earnings History > 8 > eps Estimate
-0.22
Earnings History > 8 > eps Difference
0.0338
Earnings History > 8 > surprise Percent
15.3636
Earnings History > 9 > period
2023-06-30
Earnings History > 9 > report Date
2023-08-21
Earnings History > 9 > date
2023-06-30
Earnings History > 9 > before After Market
AfterMarket
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
-0.13
Earnings History > 9 > eps Estimate
-0.23
Earnings History > 9 > eps Difference
0.1
Earnings History > 9 > surprise Percent
43.4783
Earnings History > 10 > period
2023-03-31
Earnings History > 10 > report Date
2023-05-22
Earnings History > 10 > date
2023-03-31
Earnings History > 10 > before After Market
AfterMarket
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
-0.16
Earnings History > 10 > eps Estimate
-0.23
Earnings History > 10 > eps Difference
0.07
Earnings History > 10 > surprise Percent
30.4348
Earnings History > 11 > period
2022-12-31
Earnings History > 11 > report Date
2023-03-01
Earnings History > 11 > date
2022-12-31
Earnings History > 11 > before After Market
-
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
-0.22
Earnings History > 11 > eps Estimate
-0.22
Earnings History > 11 > eps Difference
0
Earnings History > 11 > surprise Percent
0
Earnings History > 12 > period
2022-09-30
Earnings History > 12 > report Date
2022-11-14
Earnings History > 12 > date
2022-09-30
Earnings History > 12 > before After Market
AfterMarket
Earnings History > 12 > currency
USD
Earnings History > 12 > eps Actual
-0.18
Earnings History > 12 > eps Estimate
-0.19
Earnings History > 12 > eps Difference
0.01
Earnings History > 12 > surprise Percent
5.2632
Earnings History > 13 > period
2022-06-30
Earnings History > 13 > report Date
2022-08-15
Earnings History > 13 > date
2022-06-30
Earnings History > 13 > before After Market
AfterMarket
Earnings History > 13 > currency
USD
Earnings History > 13 > eps Actual
-0.06
Earnings History > 13 > eps Estimate
-0.19
Earnings History > 13 > eps Difference
0.13
Earnings History > 13 > surprise Percent
68.4211
Earnings History > 14 > period
2022-03-31
Earnings History > 14 > report Date
2022-05-20
Earnings History > 14 > date
2022-03-31
Earnings History > 14 > before After Market
AfterMarket
Earnings History > 14 > currency
USD
Earnings History > 14 > eps Actual
-0.15
Earnings History > 14 > eps Estimate
-0.19
Earnings History > 14 > eps Difference
0.04
Earnings History > 14 > surprise Percent
21.0526
Earnings History > 15 > period
2021-12-31
Earnings History > 15 > report Date
2022-03-21
Earnings History > 15 > date
2021-12-31
Earnings History > 15 > before After Market
AfterMarket
Earnings History > 15 > currency
USD
Earnings History > 15 > eps Actual
-0.18
Earnings History > 15 > eps Estimate
-0.07
Earnings History > 15 > eps Difference
-0.11
Earnings History > 15 > surprise Percent
-157.1429
Earnings History > 16 > period
2021-09-30
Earnings History > 16 > report Date
2021-11-15
Earnings History > 16 > date
2021-09-30
Earnings History > 16 > before After Market
AfterMarket
Earnings History > 16 > currency
USD
Earnings History > 16 > eps Actual
-0.07
Earnings History > 16 > eps Estimate
-0.06
Earnings History > 16 > eps Difference
-0.01
Earnings History > 16 > surprise Percent
-16.6667
Earnings History > 17 > period
2021-06-30
Earnings History > 17 > report Date
2021-08-13
Earnings History > 17 > date
2021-06-30
Earnings History > 17 > before After Market
AfterMarket
Earnings History > 17 > currency
USD
Earnings History > 17 > eps Actual
-0.06
Earnings History > 17 > eps Estimate
-0.06
Earnings History > 17 > eps Difference
0
Earnings History > 17 > surprise Percent
0
Earnings History > 18 > period
2021-03-31
Earnings History > 18 > report Date
2021-05-20
Earnings History > 18 > date
2021-03-31
Earnings History > 18 > before After Market
AfterMarket
Earnings History > 18 > currency
USD
Earnings History > 18 > eps Actual
-0.05
Earnings History > 18 > eps Estimate
-0.26
Earnings History > 18 > eps Difference
0.21
Earnings History > 18 > surprise Percent
80.7692
Earnings History > 19 > period
2020-12-31
Earnings History > 19 > report Date
2021-03-31
Earnings History > 19 > date
2020-12-31
Earnings History > 19 > before After Market
AfterMarket
Earnings History > 19 > currency
USD
Earnings History > 19 > eps Actual
-0.12
Earnings History > 19 > eps Estimate
-0.93
Earnings History > 19 > eps Difference
0.81
Earnings History > 19 > surprise Percent
87.0968
Earnings History > 20 > period
2020-09-30
Earnings History > 20 > report Date
2020-11-16
Earnings History > 20 > date
2020-09-30
Earnings History > 20 > before After Market
AfterMarket
Earnings History > 20 > currency
USD
Earnings History > 20 > eps Actual
-0.03
Earnings History > 20 > eps Estimate
-0.03
Earnings History > 20 > eps Difference
0
Earnings History > 20 > surprise Percent
0
Earnings History > 21 > period
2020-06-30
Earnings History > 21 > report Date
2020-09-28
Earnings History > 21 > date
2020-06-30
Earnings History > 21 > before After Market
AfterMarket
Earnings History > 21 > currency
USD
Earnings History > 21 > eps Actual
-0.02
Earnings History > 21 > eps Estimate
0
Earnings History > 21 > eps Difference
-0.02
Earnings History > 21 > surprise Percent
-
Earnings History > 22 > period
2020-03-31
Earnings History > 22 > report Date
2020-06-23
Earnings History > 22 > date
2020-03-31
Earnings History > 22 > before After Market
-
Earnings History > 22 > currency
USD
Earnings History > 22 > eps Actual
-0.02
Earnings History > 22 > eps Estimate
0
Earnings History > 22 > eps Difference
-0.02
Earnings History > 22 > surprise Percent
-
Earnings History > 23 > period
2019-12-31
Earnings History > 23 > report Date
2020-01-28
Earnings History > 23 > date
2019-12-31
Earnings History > 23 > before After Market
-
Earnings History > 23 > currency
USD
Earnings History > 23 > eps Actual
-0.27
Earnings History > 23 > eps Estimate
0
Earnings History > 23 > eps Difference
-0.27
Earnings History > 23 > surprise Percent
-
Earnings History > 24 > period
2019-06-30
Earnings History > 24 > report Date
2019-09-30
Earnings History > 24 > date
2019-06-30
Earnings History > 24 > before After Market
-
Earnings History > 24 > currency
USD
Earnings History > 24 > eps Actual
-1.1516
Earnings History > 24 > eps Estimate
0
Earnings History > 24 > eps Difference
-1.1516
Earnings History > 24 > surprise Percent
-
Earnings History > 25 > period
2019-03-31
Earnings History > 25 > report Date
2019-06-30
Earnings History > 25 > date
2019-03-31
Earnings History > 25 > before After Market
-
Earnings History > 25 > currency
USD
Earnings History > 25 > eps Actual
-12.828
Earnings History > 25 > eps Estimate
0
Earnings History > 25 > eps Difference
-12.828
Earnings History > 25 > surprise Percent
-
Earnings History > 26 > period
2018-12-31
Earnings History > 26 > report Date
2019-03-31
Earnings History > 26 > date
2018-12-31
Earnings History > 26 > before After Market
-
Earnings History > 26 > currency
USD
Earnings History > 26 > eps Actual
-0.7327
Earnings History > 26 > eps Estimate
0
Earnings History > 26 > eps Difference
-0.7327
Earnings History > 26 > surprise Percent
-
Greenwich LifeSciences, Inc., a clinical-stage biopharmaceutical company, develops novel cancer immunotherapies for breast cancer and other HER2/neu-expressing cancers in the United States and Romania. Its lead product candidate is GP2, an immunotherapy, which is in Phase III clinical trial to prevent breast cancer recurrences in patients who have previously undergone surgery. The company also develops FLAMINGO-01, which is in Phase III clinical trial designed to evaluate the safety and efficacy of GLSI-100 (GP2 + GM-CSF) in HER2 positive breast cancer patients. Greenwich LifeSciences, Inc. was formerly known as Norwell, Inc. and changed its name to Greenwich LifeSciences, Inc. in March 2018. The company was incorporated in 2006 and is headquartered in Stafford, Texas.
Stock Price
$ 0.00
0% decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AShowing 2 of 10
(Last Updated 2025-09-30)
Rating:
BUY
Target Price:
$45
Analyst Picks
Strong Buy
0
Buy
1
Hold
0
Sell
0
Strong Sell
0
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very High
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Debt to Equity
-
Low
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 15.09% of the total shares of Greenwich Lifesciences Inc
1.
BlackRock Inc(2.6939%)
since
2025/06/30
2.
Vanguard Group Inc(1.9736%)
since
2025/06/30
3.
iShares Russell 2000 ETF(1.1378%)
since
2025/08/31
4.
Vanguard Total Stock Mkt Idx Inv(1.1018%)
since
2025/07/31
5.
Geode Capital Management, LLC(1.0197%)
since
2025/06/30
6.
Crédit Agricole S.A.(0.6383%)
since
2025/03/31
7.
PV BUYBACK USA Classe B USD(0.6383%)
since
2025/03/31
8.
Northern Trust Corp(0.6073%)
since
2025/06/30
9.
State Street Corp(0.6034%)
since
2025/06/30
10.
Fidelity Small Cap Index(0.4483%)
since
2025/06/30
11.
Marshall Wace Asset Management Ltd(0.4119%)
since
2025/06/30
12.
Vanguard Institutional Extnd Mkt Idx Tr(0.4014%)
since
2025/07/31
13.
iShares Russell 2000 Growth ETF(0.3532%)
since
2025/08/31
14.
Millennium Management LLC(0.2508%)
since
2025/06/30
15.
Fidelity Extended Market Index(0.2276%)
since
2025/07/31
16.
Vanguard Russell 2000 ETF(0.2138%)
since
2025/07/31
17.
State St Russell Sm Cap® Indx SL Cl I(0.2091%)
since
2025/08/31
18.
Renaissance Technologies Corp(0.2003%)
since
2025/06/30
19.
STRS OHIO(0.1467%)
since
2025/06/30
20.
Charles Schwab Investment Management Inc(0.1398%)
since
2025/06/30
21.
HighTower Advisors, LLC(0.1245%)
since
2025/06/30
22.
Goldman Sachs Group Inc(0.121%)
since
2025/06/30
23.
Schwab Small Cap Index(0.1195%)
since
2025/07/31
24.
NT R2000 Index Fund - NL(0.1143%)
since
2025/06/30
25.
Bank of New York Mellon Corp(0.1071%)
since
2025/06/30
26.
Citadel Advisors Llc(0.101%)
since
2025/06/30
27.
iShares Micro-Cap ETF(0.0996%)
since
2025/08/31
28.
NT R2000 Index Fund - DC - NL - 3(0.0911%)
since
2025/06/30
29.
iShares Russell 2000 Small-Cap Idx Instl(0.0873%)
since
2025/07/31
30.
Morgan Stanley - Brokerage Accounts(0.0863%)
since
2025/06/30
31.
Fidelity Total Market Index(0.0777%)
since
2025/07/31
32.
Barclays PLC(0.0776%)
since
2025/06/30
33.
Extended Equity Market Fund K(0.0758%)
since
2025/06/30
34.
Russell 2500™ Index Fund F(0.0659%)
since
2025/06/30
35.
Rhumbline Advisers(0.0658%)
since
2025/06/30
36.
Nuveen Small Cap Blend Idx R6(0.0596%)
since
2025/07/31
37.
Goldman Sachs Absolute Ret Trckr Instl(0.0595%)
since
2025/06/30
38.
Fidelity Series Total Market Index(0.0563%)
since
2025/07/31
39.
New York State Common Retirement Fund(0.044%)
since
2025/06/30
40.
Bank of America Corp(0.0384%)
since
2025/06/30
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2025-09-30
EPS Actual
-0.3
EPS Estimate
-0.23
EPS Difference
-0.07
Surprise Percent
-30.4348%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.